![Jonas Karl Hansson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jonas Karl Hansson
Plus aucun poste en cours
Profil
Jonas Karl Hansson is the founder of Purpose Pharma International AB. He currently holds the position of Executive Chairman at Tribune Therapeutics AB, Director at FE Fonder AB, Partner at Healthcap VI GP SA, Partner at HealthCap Advisor AB, and Partner at HealthCap VII GP SA. Previously, he served as the Chief Executive Officer of Wilson Therapeutics AB from 2012 to 2018.
He also held the position of Independent Director at Spruce Biosciences, Inc. in 2021.
Additionally, he has worked as a Director at Revent Medical, Inc. and Prothelia, Inc. Furthermore, he was a Partner at HealthCap AB from 2008 to 2022.
He started his career as a Key Account Manager at Janssen Pharma AB. Mr. Hansson obtained an MBA from Stockholm School of Economics in 2008 and graduated from the University of Uppsala in 2000.
Postes actifs de Jonas Karl Hansson
| Sociétés | Poste | Début |
|---|---|---|
Healthcap VI GP SA | Corporate Officer/Principal | - |
HealthCap VII GP SA | Corporate Officer/Principal | - |
HealthCap Advisor AB
 HealthCap Advisor AB Investment ManagersFinance Provides investment advice | Corporate Officer/Principal | 01/01/2019 |
Tribune Therapeutics AB
 Tribune Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Operates as preclinical biopharmaceutical company that develops medicines to treat patients with fibrotic diseases | Président | - |
FE Fonder AB
 FE Fonder AB Investment ManagersFinance Provides investment advice | Directeur/Membre du Conseil | - |
Anciens postes connus de Jonas Karl Hansson
| Sociétés | Poste | Fin |
|---|---|---|
HealthCap AB
 HealthCap AB Investment ManagersFinance HealthCap invests in companies located across the globe. The firm targets companies operating in the field of the life sciences. It provides financing for early stage capital requirements. | Analyste en capital-investissement | 01/06/2012 |
| SPRUCE BIOSCIENCES, INC. | Directeur/Membre du Conseil | 20/05/2021 |
| WILSON THERAPEUTICS AB | Directeur Général | 01/06/2018 |
Janssen Pharma AB | Corporate Officer/Principal | - |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Jonas Karl Hansson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
74
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Revent Medical, Inc.
 Revent Medical, Inc. Pharmaceuticals: MajorHealth Technology Develops cost effective and innovative medical implants for patients with obstructive sleep apnea | Health Technology |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap invests in companies located across the globe. The firm targets companies operating in the field of the life sciences. It provides financing for early stage capital requirements. | Finance |
Stockholm School of Economics
 Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Healthcap VI GP SA | |
Wilson Therapeutics AB
 Wilson Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company focusing in treatment of Wilson disease | Health Technology |
HealthCap Advisor AB
HealthCap Advisor AB Investment ManagersFinance Provides investment advice | Finance |
HealthCap VII GP SA | |
Spruce Biosciences, Inc.
 Spruce Biosciences, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company which develops novel therapies for endocrine diseases | Health Technology |
Prothelia, Inc.
 Prothelia, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops therapies | Health Technology |
Tribune Therapeutics AB
Tribune Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Operates as preclinical biopharmaceutical company that develops medicines to treat patients with fibrotic diseases | Commercial Services |
FE Fonder AB
FE Fonder AB Investment ManagersFinance Provides investment advice | Finance |
Janssen Pharma AB |
